AR and triple-negative breast carcinoma: Recently, seven different subtypes have been described for the triple-negative breast cancer based on analysis of gene expression profiles: basal-like 1 (BL1), basal-like 2 (BL2), immunomodulatory (IM), mesenchymal-like (M), mesenchymal stem–like (MSL), luminal androgen receptor (LAR), and unstable (UNS) [92].